Affiance Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Affiance Financial’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150	Closed	-$4.23K	–	118
2022 Q4	$4.23K	Buy	+150	New	+$4.76K	﹤0.01%	346
2021 Q4	–	Sell	-150	Closed	-$11K	–	147
2021 Q3	$11K	Hold	150	–	–	﹤0.01%	150
2021 Q2	$14K	Hold	150	–	–	0.01%	147
2021 Q1	$13K	Buy	+150	New	+$14.9K	0.01%	143

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Affiance Financial's ARKG Position: Q1 2023 in Review

Affiance Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 150 shares — an estimated $4.23K sold.

Affiance Financial first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $14K in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Affiance Financial reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Affiance Financial sold 150 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $4.23K.
Affiance Financial first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
Affiance Financial's ARK Genomic Revolution ETF position peaked at $14K in Q2 2021.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Affiance Financial's 13F filing for Q1 2023, filed 18 Apr 2023.